Physician profile
Amer Y Sayed
NPI 1467892372
$31,098.11
in general payments reported to CMS, 2019-2025
20 companies · $961 in 2025
The $961 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,870 · 2020: $357 · 2021: $2,227 · 2022: $18K · 2023: $4,453 · 2024: $3,041 · 2025: $961.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $5,298 · Food and Beverage: $3,156 · Education: $1.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $5,297.89 |
| Food and Beverage | $3,155.91 |
| Education | $1.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $16,069.07 | 2021-2025 | Corevalve Evolut R, Symplicity G3 |
| Abbott Laboratories | $5,076.13 | 2019-2025 | Optis, Mitraclip, Triclip |
| Edwards Lifesciences Corporation | $4,835.92 | 2021-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Pascal |
| Penumbra, INC. | $2,149.47 | 2024 | Indigo System |
| Medical Device Business Services, INC. | $1,069.90 | 2023-2024 | Carto 3 |
| Philips North America LLC | $324.99 | 2019-2024 | (Bh4) Igt Devices Undivided, (5028) Igt Devices Systems Undivided |
| Boston Scientific Corporation | $226.99 | 2023-2025 | Opticross, Watchman Flx, Fighter |
| Cardiovascular Systems INC. | $223.93 | 2021-2023 | Diamondback Peripheral |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $211.02 | 2019-2024 | Lifevest |
| Medtronic Vascular, INC. | $185.99 | 2019 | |
| Astrazeneca Pharmaceuticals Lp | $155.87 | 2019-2021 | |
| Gilead Sciences, INC. | $112.30 | 2022 | |
| Teladoc Health, INC. | $100.00 | 2022 | |
| Chiesi USA, INC. | $88.36 | 2021 | |
| Cardiva Medical, INC. | $65.45 | 2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $53.92 | 2022-2024 | Xarelto |
| Reflow Medical INC | $53.33 | 2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $40.91 | 2024 | Jardiance |
| Abiomed | $34.85 | 2025 | |
| Lantheus Medical Imaging, INC. | $19.71 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amer Sayed listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.